Kestra Advisory Services’s SAB Biotherapeutics SABS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.9K | Hold |
|
|||||
|
2025
Q1 | $16.2K | Hold |
|
|||||
|
2024
Q4 | $45.3K | Hold |
|
|||||
|
2024
Q3 | $32.2K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $60.5K | Buy |
|
|||||
|
2023
Q3 | $13.2K | Hold |
|
|||||
|
2023
Q2 | $17.4K | Buy |
|
|||||
|
2023
Q1 | $4.84K | Hold |
|
|||||
|
2022
Q4 | $6.49K | Hold |
|
|||||
|
2022
Q3 | $8K | Hold |
|
|||||
|
2022
Q2 | $16K | Buy |
|